Applied Biosciences Corp. Stock

APPB

US03815L1026

Biotechnology & Medical Research

Market Closed - OTC Markets 10:01:16 2025-12-08 EST			5-day change	1st Jan Change
0.000100 ^USD	-99.90%		-.--%	-

20-04-24	Applied BioSciences Corp. Terminates Agreement to Offer Test Kits	CI
20-03-31	Applied BioSciences Begins Offering Coronavirus Test Kit to the General Public to Combat Spread of COVID-19	CI

Valuation: Applied Biosciences Corp.

Market Cap	11.43M 10.18M 9.43M 8.54M 16.06M 1.08B 16.27M 113M 44.32M 567M 42.89M 41.99M 1.81B	P/E 2018	-12.7x	P/E 2019	-7.7x
Enterprise Value	11.41M 10.16M 9.41M 8.52M 16.03M 1.08B 16.24M 113M 44.23M 566M 42.81M 41.91M 1.8B	EV / Sales 2018	104,018,506x	EV / Sales 2019	32,047,470x
Free-Float	65.92%	Yield 2018 *	-	Yield 2019	-

* Estimated data More valuation ratios

Chart: Applied Biosciences Corp.

Dynamic Chart

Latest news: Applied Biosciences Corp.

20-04-24	Applied BioSciences Corp. Terminates Agreement to Offer Test Kits	CI
20-03-31	Applied BioSciences Begins Offering Coronavirus Test Kit to the General Public to Combat Spread of COVID-19	CI
20-03-19	Applied Biosciences Corp. Announces Resignation of Raymond Urbanski as Chief Executive Officer and Director	CI
20-02-18	Applied Biosciences Corp. Reports Earnings Results for the Third Quarter Ended December 31, 2019	CI
19-11-14	Applied Biosciences Corp. Reports Earnings Results for the Second Quarter Ended September 30, 2019	CI
19-10-17	Pond Naturals Signs Agreement with Applied BioSciences to Sell its X10 Pet Supplement in the US alongside CBD-based Herbal Pet products	CI
19-10-07	Applied Biosciences Corp. Appoints Michael Beaubaire as Director	CI
19-09-16	Applied BioSciences Corp. Announces Resignation of John Brady as Director	CI
19-09-08	Applied Biosciences Corp. announced that it has received $0.25 million in funding from FirstFire Capital Management LLC	CI
19-09-03	Applied Biosciences Corp. announced that it expects to receive $0.5 million in funding from FirstFire Capital Management LLC	CI
19-08-14	Applied Biosciences Corp. Reports Earnings Results for the First Quarter Ended June 30, 2019	CI
19-07-01	Applied Biosciences Corp. Reports Earnings Results for the Full Year Ended March 31, 2019	CI
19-06-30	Applied Biosciences Corp. Auditor Raises 'Going Concern' Doubt	CI

More news

Press Releases: Applied Biosciences Corp.

25-03-05	Biocon Academy Conducts its 9th Graduation Day	AQ
23-12-20	Biocon Academy Conducts its 8th Graduation Day	AQ
23-05-17	University of Sunderland in London : Study dips into world of Wild Sea Women	AQ
23-04-06	Biocon Academy Conducted Graduation Ceremony for 185 Students across Four Programs	AQ
20-07-08	Applied Biosciences : Pandemic For Profit? – SEC Enforcement Patrols Press Releases	AQ

More press releases

Managers and Directors: Applied Biosciences Corp.

Manager	Title	Age	Since
David Colodner PSD	President	-	-

Director	Title	Age	Since
David Colodner BRD	Director/Board Member	-	-

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
APPLIED BIOSCIENCES CORP.	-99.90%	-.--%	-.--%	-50.00%	2.14K
WUXI APPTEC CO., LTD.	-0.21%	-6.36%	+49.00%	+74.13%	66.34B
LONZA GROUP AG	-0.22%	+10.10%	+12.77%	+87.32%	52.92B
ARGENX SE	+0.82%	+9.46%	+7.75%	+73.53%	54.82B
IQVIA HOLDINGS INC.	+3.28%	+6.12%	+30.46%	+50.05%	44.09B
BEONE MEDICINES AG	+0.51%	+10.71%	+21.30%	+133.92%	43.72B
REVOLUTION MEDICINES, INC.	-1.15%	+3.10%	+259.71%	+594.60%	42.13B
CELLTRION, INC.	+0.10%	+9.96%	+17.15%	+59.33%	33.96B
WUXI BIOLOGICS (CAYMAN) INC.	-1.30%	-3.61%	+37.37%	+7.16%	26.17B
GENMAB A/S	+0.69%	+6.07%	+31.89%	+26.94%	23.37B
Average	-9.74%	+4.30%	+46.74%	+105.70%	38.75B
Weighted average by Cap.	+0.32%	+4.67%	+51.28%	+127.77%

See all sector performances

Applied BioSciences Corp. is a vertically integrated company focused on developing science-driven cannabinoid therapeutics/biopharmaceuticals and delivering Cannabidiol (CBD) products. The Company operates in one segment for product and service distribution. It sells consumer products including creams, tinctures, edibles, confections, clothing, apparel, and branded products. It is involved in the bioceutical and pet health industries, distributing products to the U.S. states and various international markets. It focuses on investments, consumer brands, and partnerships in the recreational, health and wellness, nutraceutical, and media industries. It sources products from facilities in California, Colorado, Nevada, and Florida. The Company's brands include Remedi, Remedi Plus, HerbalPet, Champ Organics, and Equine Care. Its subsidiaries include Trace Analytics, Inc., VitaCBD LLC, API Holdings, and Applied Products LLC.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume

Real-time OTC Markets

More quotes

Stock Market
Stocks
APPB Stock

As early as today, start finding the best investment opportunities!

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0.1
10 years	0		5

	2018	2019
Net sales	0.2 0.18 0.16 0.15 0.28 18.66 0.28 1.95 0.77 9.8 0.74 0.73 31.24	0.71 0.63 0.58 0.53 0.99 66.78 1.01 6.99 2.74 35.07 2.65 2.6 111.81
Net income	-2.38M -2.12M -1.96M -1.77M -3.34M -224M -3.38M -23.5M -9.21M -118M -8.91M -8.73M -376M	-2.63M -2.34M -2.17M -1.96M -3.69M -248M -3.74M -26.01M -10.19M -130M -9.86M -9.66M -416M
Net Debt	-60.93K -54.25K -50.23K -45.5K -85.59K -5.76M -86.73K -603K -236K -3.02M -229K -224K -9.64M	-22.04K -19.63K -18.17K -16.46K -30.96K -2.08M -31.38K -218K -85.44K -1.09M -82.69K -80.96K -3.49M

Applied Biosciences Corp. Stock

Stocks

APPB

US03815L1026

Biotechnology & Medical Research

Valuation: Applied Biosciences Corp.

Chart: Applied Biosciences Corp.

Latest news: Applied Biosciences Corp.

Press Releases: Applied Biosciences Corp.

Quotes and Performance

Price Extremes

Managers and Directors: Applied Biosciences Corp.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes